Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00142324
Status:
UNKNOWN
Last Update Posted:
2005-12-14
First Post:
2005-09-01
Brief Title:
CALM-AD
Sponsor:
Institute of Psychiatry London
Organization:
Institute of Psychiatry London
Study Overview
Official Title:
A Randomised Placebo Controlled Trial of a Cholinesterase Inhibitor in the Management of Agitation in Dementia That is Unresponsive to a Psychological Intervention
Status:
UNKNOWN
Status Verified Date:
2005-09
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Primary Aim
To determine whether
Donepezil is significantly better than placebo in the management of agitation in Alzheimers Disease that has not responded to or is inappropriate for a standardised brief psychosocial treatment
Secondary Aims
To determine whether
Donepezil has a significant positive or negative impact upon quality of life compared with placebo
whether there is a significant difference between Donepezil and placebo with respect to cognitive performance
the cost effectiveness of the pharmacological treatment for agitation
To determine whether
Donepezil is significantly better than placebo in the management of agitation in Alzheimers Disease that has not responded to or is inappropriate for a standardised brief psychosocial treatment
Secondary Aims
To determine whether
Donepezil has a significant positive or negative impact upon quality of life compared with placebo
whether there is a significant difference between Donepezil and placebo with respect to cognitive performance
the cost effectiveness of the pharmacological treatment for agitation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None